Empagliflozin 12.5mg + Metformin 500mg Tablets

Empagliflozin 12.5mg + Metformin 500mg combines empagliflozin with metformin for adults with type 2 diabetes when both medicines fit the treatment plan. Together they address different glucose pathways without repeating the same action. Use is limited to type 2 diabetes management. It should not be used for type 1 diabetes or diabetic ketoacidosis. Temporary interruption may be needed around iodinated contrast imaging, serious illness, dehydration, major surgery, or prolonged fasting. Long-term metformin may lower vitamin B12 in some patients.
Take Empagliflozin + Metformin 12.5mg + 500mg as prescribed, usually with food to reduce metformin stomach upset. Swallow ER/XR tablets whole if applicable. Follow glucose, kidney-test, hydration, sick-day, surgery, and contrast-procedure instructions.
Empagliflozin blocks kidney SGLT2 transporters so more glucose leaves in urine. Metformin lowers hepatic glucose production and improves insulin sensitivity.
Possible effects include nausea, diarrhoea, stomach upset, metallic taste, increased urination, thirst, genital fungal infection, urinary infection, dizziness, and dehydration. Serious warning signs include lactic acidosis, ketoacidosis, severe infection, kidney problems, or allergic reaction.
Review kidney disease, liver disease, heart failure, alcohol use, dehydration, contrast imaging, surgery, pregnancy, breastfeeding, recurrent infections, insulin/sulfonylureas, diuretics, and vitamin B12 monitoring.
Treatment support for the listed condition
UsesType 2 diabetes glucose control in adults when empagliflozin plus metformin is prescribed.BenefitsCombines kidney glucose excretion with metformin's insulin-sensitising and liver-glucose effects for complementary glucose lowering.
Empagliflozin 12.5mg + Metformin 500mg Tablets is used in type 2 diabetes management and blood-sugar control.
Empagliflozin 12.5mg + Metformin 500mg Tablets is usually taken by mouth with water. Timing and frequency can vary by therapy area, so the product leaflet or professional direction should be followed.
Empagliflozin + Metformin works by reducing glucose production in the liver and improving the body’s response to insulin. This helps support its role in blood-sugar control in type 2 diabetes.
Common side effects may include nausea, diarrhoea, stomach upset, metallic taste, loss of appetite or weakness. Side effects can vary from person to person and by formulation.
Check the active ingredient, strength, pack size, manufacturer, expiry, storage instructions and whether the medicine is suitable for people with kidney disease, liver disease, heavy alcohol use, dehydration, severe infection or planned contrast scans or those taking interacting medicines.
Empagliflozin, empagliflozin, エンパグリフロジン, Empagliflozina, 恩格列淨, empagliflozine, أمباغليفلوزين, Empagliflozină, Εμπαγλιφλοζίνη, امپاگلیفلوزین, empagliflotsiini, empagliflozyna, אמפאגליפלוזין, 엠파글리플로진, Емпагліфлозин, эмпаглифлозин, BI 10773, BI-10773, BI10773, 1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene, Jardiance
International B2B Enquiry
Send a structured B2B enquiry for Empagliflozin 12.5mg + Metformin 500mg Tablets under Diabetes Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Empagliflozin 12.5mg + Metformin 500mg Tablets